Pulsatile arterial haemodynamics in heart failure
نویسندگان
چکیده
منابع مشابه
Looking beyond haemodynamics in chronic heart failure.
We read with great interest the excellent review article on drug therapy in chronic heart failure (CHF) by McKenzie and Cowley. The authors discuss the haemodynamic, neurohormonal, and sympathetic nervous system mechanisms contributing to heart failure, but maintain a cardiocentric view in explaining how these three mechanisms together lead to the deterioration of the failing heart and its haem...
متن کاملPulsatile hemodynamics in congestive heart failure.
Pulse pressure, an indirect measure of vascular stiffness and pulsatile load, predicts clinical events in congestive heart failure (CHF), suggesting that abnormal pulsatile load may contribute to CHF. This study was designed to assess more direct measures of central pulsatile load in CHF. Noninvasive hemodynamic evaluations were performed in 28 subjects with CHF and 40 controls using calibrated...
متن کاملPulsatile hemodynamics and clinical outcomes in acute heart failure.
BACKGROUND The role of pulsatile hemodynamics in the management of patients with acute heart failure syndrome (AHFS) remains to be elucidated. We investigated the changes of the pulsatile hemodynamics along the hospital course of AHFS in relation to short-term outcomes. METHODS A total of 80 AHFS patients (73.2 ± 14.1 years, 82.5% men) were enrolled and followed up for up to 6 months after di...
متن کاملSex and haemodynamics in pulmonary arterial hypertension.
Female sex is a risk factor for pulmonary arterial hypertension (PAH), yet females have better survival than males. We sought to determine if sex was associated with baseline haemodynamics in subjects with PAH, and whether age modified these relationships. We conducted a pooled analysis from 11 randomised trials submitted to the US Food and Drug Administration. The study sample included 1211 su...
متن کاملEndothelial dysfunction, arterial stiffness, and heart failure.
Outcomes for heart failure (HF) patients remain suboptimal. No known therapy improves mortality in acute HF and HF with preserved ejection fraction; the most recent HF trial results have been negative or neutral. Improvement in surrogate markers has not necessarily translated into better outcomes. To translate breakthroughs with potential therapies into clinical benefit, a better understanding ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Heart Journal
سال: 2018
ISSN: 0195-668X,1522-9645
DOI: 10.1093/eurheartj/ehy346